netFormulary NHS
Southampton Joint Formulary

Looking for Alemtuzumab found 4 matches

Formulary BNF Category
Other immunomodulating drugs - 08.02.04

Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section EMA Safety Update: Use of alemtuzumab restricted while review is ongoing Apr 2019 (08.02.04)
link in drug section NHS England Urgent Clinical Commissioning Policy Statement: Alemtuzumab for treating relapsing-remitting multiple sclerosis - third cycle (all stages) Aug 2018 (08.02.04)
link in drug section NICE TA312: Alemtuzumab for relapsing‑remitting multiple sclerosis (08.02.04)